Though most S&P 500 CEOs received raises of 8 percent or better last year, many companies across all industries have announced salary reductions for CEOs this year due to financial pressures linked to the COVID-19 pandemic.
Below are the 20 healthcare industry CEOs with the biggest packages in 2019, according to WSJ‘s analysis of compensation for leaders of S&P 500 companies.
1. Larry J. Merlo, CVS Health: $36.5 million
2. Daniel O’Day, Gilead Sciences: $29.1 million
3. Miles D. White, Abbott Laboratories: $27.8 million
4. Kenneth C. Frazier, Merck: $27.6 million
5. Samuel N. Hazen, HCA Healthcare: $26.8 million
6. Michael F. Neidorff, Centene: $26.4 million
7. Alex Gorsky, Johnson & Johnson: $25.4 million
8. Alan B. Miller, Universal Health Services: $24.5 million
9. Richard A. Gonzalez, AbbVie: $21.6 million
10. Leonard S. Schleifer, Regeneron: $21.5 million
11. David A. Ricks, Eli Lilly: $21.3 million
12. Robert A. Bradway, Amgen: $19.6 million
13. David Cordani, Cigna: $19.3 million
14. Stefano Pessina, Walgreens: $19.2 million
15. Marc N. Casper, Thermo Fisher Scientific: $19 million
16. Ludwig Hantson, Alexion Pharmaceuticals: $18.9 million
T-16. David S. Wichmann, UnitedHealth: $18.9 million
18. Giovanni Caforio, Bristol-Myers Squibb: $18.8 million
19. Heather M. Bresch, Mylan: $18.5 million
20. Michel Vounatsos, Biogen: $18.2 million
More articles on compensation:
Physician compensation grew most for these 5 specialties
10 lowest-paying states for nurse practitioners
More companies center cost-cutting strategies on ‘shared pain’ than in past downturns
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
